Clinical Trial Update: Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing methotrexate to dactinomycin in gestational trophoblastic neoplasia has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choriocarcinoma Uterine Corpus
• Gestational Trophoblastic Neoplasia
• Hydatidiform Mole

Drugs mentioned

• Dactinomycin (dactinomycin)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Good Prognosis Metastatic Gestational Trophoblastic Tumor, Hydatidiform Mole | Phase 3 | Status: COMPLETED | Results posted: 2018-05-15